The FDA has approved nivolumab (Opdivo) plus AVD as first-line treatment for advanced classical Hodgkin lymphoma in patients ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

The FDA has approved nivolumab (Opdivo) plus doxorubicin, vinblastine, and dacarbazine (AVD) for the treatment of adult and pediatric patients age 12 and older with treatment-naiv ...

The U.S. Food and Drug Administration (FDA) on Friday approved Bristol Myers Squibb & Co.’s BMY Opdivo (nivolumab) with chemotherapy for untreated Hodgkin lymphoma, one of the most curable forms of ...

FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...

Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) ...

In a study published today in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of ...

As of 2025, there are over 18.6 million cancer survivors in the United States, representing about 1 in 18 Americans. By the ...

A Clare Lymphoma survivor is urging people to do what they can to raise awareness and funds for vital Cancer research. Ennis ...

In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...